Intermittent leukapheresis: an adjunct to low-dose chemotherapy for Sézary syndrome
DOI:
https://doi.org/10.2340/00015555697376Abstract
Eleven patients with Sézary syndrome were treated with intermittent leukapheresis in addition to low-dose chlorambucil and prednisone. The results were as good as or better than those with chemotherapy alone. We believe the combined program with continuous leukapheresis to be optimal therapy but note that intermittent treatment offers some benefit for patients.Downloads
Download data is not yet available.
Downloads
Published
1989-01-01
How to Cite
McEvoy, M., Zelickson, B., Pineda, A., & Winkelmann, R. (1989). Intermittent leukapheresis: an adjunct to low-dose chemotherapy for Sézary syndrome. Acta Dermato-Venereologica, 69(1), 73–76. https://doi.org/10.2340/00015555697376
Issue
Section
Articles
License
Copyright (c) 1989 MT McEvoy, BD Zelickson, AA Pineda, RK WinkelmannAll digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
